Geri Kreitzer

Dr. Geri Kreitzer obtained her PhD degree from the Columbia University College of Physicians and Surgeons, New York in 1996, after when she completed postdoctoral training at the Weill Cornell Medical College in 2001. Dr. Kreitzer became Associate Medical Professor of Molecular, Cellular and Biomedical Sciences at the CUNY School of Medicine, Sophie Davis School of Biomedical Education since 2016, after her being the Associate Professor of Cell and Development Biology at the Weill Cornell Medical College from 2003-2016. Currently, Dr. Kreitzer is leading active research on the mechanisms of changes in cell shape and function that are required for normal tissue development, with projects encompassing the mechanisms of cell polarization, cargo selection by kinesin family motor proteins, kinesins’s role in non-canonical transcription, and the regulation of nuclear receptor function by kinesin in breast cancer. Dr. Kreitzer’s lab aims to apply the knowledge acquired from research towards new treatment for diseases.

Lab Information

CUNY School of Medicine, Sophie Davis School of Biomedical Education

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Epithelial cell polarization 0 kinesins 0 cytoskeletal motor proteins 0

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Wang L, Wang D, Xing B, Tan YC, Huang J, Liu B, Syrovatkina V, Espenel C, Kreitzer G, Guo L, Zhang JJ, Huang XY. G-Protein Gα13 Functions with Abl Kinase to Regulate Actin Cytoskeletal Reorganization. J Mol Biol. 2017 Dec 8;429(24):3836-3849. PMID:29079481

  2. Seneviratne A, Turan Z, Hermant A, Lecine P, Smith WO, Borg JP, Jaulin F, Kreitzer G. Modulation of estrogen related receptor alpha activity by the kinesin KIF17. Oncotarget. 2017. doi: 10.18632/oncotarget.18104. PubMed PMID: 28596477.

  3. Acharya B, Espenel C, Libanje F, Raingeaud J, Jaulin F, and Kreitzer G. KIF17 regulates RhoA-dependent actin remodeling at the epithelial cell cortex. J. Cell Science. Mar 1;129(5):957-70.

  4. Patel DM, Dubash AD, Kreitzer G, Green KJ. Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin-EB1 interactions. The Journal of cell biology. 2014;206(6):779-97.

  5. Espenel C, Acharya BR, Kreitzer G. A biosensor of local kinesin activity reveals roles of PKC and EB1 in KIF17 activation. The Journal of cell biology. 2013;203(3):445-55.


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud